Skip to main content

Clinical trial Nivothym

Single-arm, multicenter, phase II study of nivolumab in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy - (Nivothym)

Organ Thymus
Trial status Trial open for recruitment
Trial type
Interventionnal with IMP
Phase Trial phase 2
Academic trial Non
Sponsor EORTC
EudraCT Identifier 2015-005504-28
Inclusion criteria second line metastatic
Last update